We sought genetic effects on labour pain by studying healthy women who did not request analgesia 26 during their first delivery. Extensive sensory and psychometric testing were normal in these women, 27 except for significantly higher cuff-pressure pain. We found an excess of heterozygotes carrying 28 the rare allele of SNP rs140124801 in KCNG4. The rare variant KV6.4-Met419 exerts a dominant 29 negative effect and cannot modulate the voltage-dependence of KV2.1 inactivation because it fails 30 to traffic to the plasma membrane. In vivo, we observed Kcng4 (KV6.4) expression in 40% of 31 retrograde labelled mouse uterine sensory neurones, all of which expressed KV2.1, and over 90% 32 expressed nociceptor genes Trpv1 and Scn10a. In neurones overexpressing KV6.4-Met419, the 33 voltage-dependence of inactivation for KV2.1 is more depolarised compared to neurones 34 overexpressing KV6.4. Finally, KV6.4-Met419 overexpressing neurones have a higher action 35 potential threshold. We conclude KV6.4 can influence human labour pain by modulating the 36 excitability of uterine nociceptors. 37 38 BioRxiv KCNG4 Labour Pain Page 3 of 31 39 65 analgesics that were available and offered to them during labour: an observable behavioural 66 phenotype that is considered highly unusual in hospital maternity units in the United Kingdom, 67 particularly for the spontaneous delivery of term nulliparous women. Quantitative sensory testing, 68 performed with our study cohort, suggest a general increase in pain thresholds and tolerance when 69 compared to controls, but only the increase in cuff-pressure pain threshold survived statistical 70 significance after adjustment for multiple comparisons. We next assessed the allele frequencies of 71 BioRxiv KCNG4 Labour Pain Page 4 of 31 all (genome-wide) protein changing single nucleotide polymorphisms (SNPs) in these women 72 compared to population frequencies. We found that the voltage-gated potassium channel (KV) 73 modifier KCNG4 (KV6.4) SNP rs140124801 rare allele c.1255G>A p.(Val419Met) was over-74
Introduction
All eutherians (placental mammals) experience contraction of the uterus and discomfort during 41 parturition. Whilst this discomfort is universal in eutherians, it appears to be most marked in humans 42 (1). The severity of labour pain is considered a consequence of positive sexual selection in modern 43 humans (with females seeking the cleverest mate), which has led to the human brain (and head) 44 being three times the relative size of our nearest primate relatives (2). Despite neoteny (birth of 45 offspring in a relatively immature state), this imposes a need to deliver a large neonatal head through 46 the birth canal causing labour pain (3). While labour pain is clearly linked to uterine contractions 47 and cervical distension, the generation of this visceral signal and the sensory afferents involved are 48 poorly understood (4). 49 Although there are well-established ethnic, social and cultural factors that influence the experience 50 and expression of pain during labour (5), broader genetic effects on labour pain may also exist. For 51 example, women with the very rare Mendelian disorder Congenital Insensitivity to Pain due to bi-52 allelic non-functional mutations in SCN9A (OMIM: 243000) do not report labour pain or require 53 analgesics during labour (6) . SCN9A encodes for the voltage-gated sodium channel NaV1.7, 54 expressed selectively in nociceptive and autonomic neurones, and mutations in SCN9A have well- 55 documented roles in causing extremely painful or painless phenotypes (7) . The painlessness 56 conferred by loss of function SCN9A mutations is clearly maladaptive and can be associated with 57 severe injury during human parturition (8). 58 Our aim here was not to discover very rare Mendelian mutations that cause extreme painlessness, 59 for example, congenital insensitivity to pain. Instead, the genetic analyses employed here are 60 optimized for investigation of phenotypes that require both an environmental trigger and genetic 61 predisposition, that will not appear to have a Mendelian inheritance pattern, unless the triggering 62 event is frequent (9). This approach is suited to the study of labour pain, which may be considered 63 nociceptive in nature, with parturition serving as visceral stimulus. We sought to identify functional 64 SNP alleles that are over-or under-represented in a cohort of women who did not request or use
RESULTS

79
Identifying women who did not require analgesics during labour as 80 nulliparous parturients: the test cohort 81 1029 potential cases were identified from 8 maternity units in the United Kingdom over a three- 82 year period. Each potential case was invited to contact researchers, as chronologically ascertained. 83 383 women responded and were screened via telephone ( Figure S1A ). Key inclusion criteria were: 84 healthy Caucasian women who experienced term (beyond 37-week gestation) and spontaneous 85 vaginal delivery as nulliparous parturients without any use or request for any form of systemic or 86 regional analgesia (spinal or epidural). We excluded women who had major disease or co-87 morbidities that are known to influence labour pain or pain in general. 189 women met the full 88 eligibility criteria (Table S1) , returned written consent, and donated either 10 ml of blood (collected 89 at their local hospital) or 2 ml of saliva sent via post, from which DNA was extracted. 90 
91
Of the women who donated DNA, 39 consented for a subsequent study of psychometrics and 92 quantitative sensory testing. These women comprised a subset of the genetic discovery cohort for 93 a case-controlled study ( Figure S1B ). For the control cohort, we recruited 33 women who were 94 matched in age at delivery of the firstborn and location of maternity service, but who used 95 analgesics during labour and delivery of their firstborn (Table S1 ). There were no significant 96 differences in the means of new-born weight or head circumference between test and control 97 cohorts (Table 1) (Table S2 ).
107
Experimental pain thresholds and tolerance are increased in the test cohort 108 Next, we quantified sensory detection and pain thresholds to cold, heat and mechanical pressure. 109 Thermal stimuli were delivered using a skin thermode applied to the forearm. Mechanical pressure 110 was exerted via compression of upper arm by a sphygmomanometer cuff. There were no significant 111 differences in the detection thresholds of cold or cuff-pressure in the test and control cohorts to 112 suggest sensory deficits or impairments pertaining to those stimuli in the test cohort (Table 1, Figure   113 S2A). Warmth detection thresholds were very slightly but significantly lower in the test cohort 114 compared to controls (0.54 °C difference) but all individual values fell within established norms 115 for the general population (15). 116 The test cohort had increased pain thresholds to heat, cold and cuff-pressure compared to controls 117 at an unadjusted significance level of P<0.05 ( Figure S2A ). There was a very striking increase of 118 over 50 mmHg in the cuff-pressure pain threshold (P = 0.00002, uncorrected; P = 0.00012, Sidak's 119 correction) (Table 1 ), suggesting that this characteristic might be relevant to the lack of analgesic 120 requirement during nulliparous labour in the test cohort. 121 During testing for tolerance to pain from the immersion of hand in cold water (3 °C), when 122 compared to controls, the test cohort showed increased hand withdrawal latency (P = 0.03, uncorrected), lower post-immersion skin temperatures (P = 0.02, uncorrected), and lower peak 124 intensity of pain on the 100 mm Visual Analogue Scale (VAS) (P = 0.004, uncorrected; P = 0.02, 125 Sidak's correction) on later assessment ( Figure S2B ). The Short-Form McGill Pain questionnaire 126 (16) revealed lower scores (P = 0.01, uncorrected; P = 0.049, corrected) for the sensory descriptors 127 for the test group. There was no between-group difference in scores related to the affective aspects 128 of the experimentally induced pain experienced (P = 0.26). These individual results do not survive 129 statistical correction for multiple comparisons but suggest that overall the test cohort of women 130 who did not request analgesia during nulliparous parturition showed greater tolerance to pain when 131 compared to controls.
132
The rare allele of rs140124801 in KCNG4 is over-represented in the test cohort 133 In 158 of the 189 women who did not require analgesics during their first labour, we obtained 134 enough high-quality DNA for molecular genetic analysis ( Figure S1 ). The chronologically first 100 135 such women (by date of banking DNA) constituted a discovery cohort ( Figure 1A) ; the next 58 136 women constituted our replication cohort. Those in the discovery cohort each had exome 137 sequencing, from which we used the bam and bam.bai files for genome wide SNP allele frequency 138 assessment using the fSNPd programme (9). The replication cohort of 58 were assessed only for 139 SNP rs140124801 alleles using Sanger sequencing of genomic DNA. 140 Our discovery cohort analysis identified one ion channel SNP where the allele frequency was 141 altered compared to reference ( Figure 1A ). The rare allele of rs140124801 in KCNG4 was over- 142 represented, being found in 3 instances, whereas 0.7 instances were expected (q=<0.05, FDR 143 corrected). We examined the individual exome results using the Integrated Genome Viewer 144 (https://software.broadinstitute.org/software/igv/) and found that 3 individuals were heterozygous 145 for the rare allele and confirmed this by Sanger sequencing. In the replication cohort, we found one 146 further rare SNP rs140124801 heterozygote. For the total cohort of 158 women not requiring 147 analgesia during their first delivery, there were 4 heterozygotes carrying the rs140124801 rare allele 148 compared to an expected 1.1 (Chi-squared two tail with Yates correction = 4.779, P = 0.0288; 149 Figure S1A ).
150
In case-controlled studies, we further explored whether 3 of the individuals who possess the rare 151 KCNG4 allele had significantly different experimental pain thresholds to those who did not (n=69, 152 Figure S1B ). We investigated pain thresholds for heat, cold and cuff-pressure, and found that the 153 rare KCNG4 allele was associated with a significantly increased cuff-pressure pain threshold (P = 154 0.0029, uncorrected; P = 0.009, Sidak's correction, Table S3 ). Although the sample size here is 155 very small because of the rarity of the KCNG4 allele being examined, the finding suggests that an effect of this rare-allele is to increase experimental cuff-pressure pain threshold in humans. The 157 experimental cuff-pressure pain remains significantly increased in the test cohort (even with the 3 158 rare-allele cases excluded, when compared with the control group (P = 0.0029, uncorrected; P = 159 0.009, Sidak's correction, Table S3 ) suggesting that cuff-pressure pain threshold might be relevant 160 to the labour pain. Whilst, there are clearly other reasons for increased cuff-pressure pain threshold 161 in those cases who do not carry the rare KCNG4 allele, these data suggest that the rare-allele of 162 KCNG4 may be related to the lack of analgesic requirement for the 3 cases we identified in this 163 study. 164 165 The rare allele of rs140124801 in KCNG4 introduces a p.Val419Met change in 167 the highly conserved K + selectivity filter consensus sequence 168 The rare allele of rs140124801 in KCNG4 causes the mis-sense change p.Val419Met encoding the 169 voltage-gated potassium channel KV6.4 (from here on referred to as KV6.4-Met419; Figure 1A -B). 170 Voltage-gated potassium channels are tetrameric complexes with each subunit having six 171 transmembrane domains (S1-S6). KV6.4 is a member of the electrically silent group of KV subunits, 172 which cannot form functional plasma membrane-expressed homotetramers, but instead act as 173 modulators of KV2 subunits (17). Indeed, KV6.4 is known to heterotetramerise with KV2.1 in a 1:3 174 stoichiometry (18). Valine 419 is in the pore forming S5-S6 linker and is part of the highly 175 conserved K + selectivity filter consensus sequence (TVGYG) ( Figure 1C 190 We used HEK293 cells as a heterologous expression system that does not express significant 191 endogenous KV currents ( Figure S3 ). As expected, over-expression of KV6.4 or KV6.4-Met419 192 alone did not produce measurable K + currents ( Figure S3E ). However, in cells expressing KV2.1 193 alone, outward currents were observed that were activated by potentials more positive than −40 mV 194 and displayed a slow inactivation ( Figure S3A ). Co-expression of KV2.1 with KV6.4 produced 195 outward currents with similar kinetics ( Figure S3D ), but we observed a small shift in the voltage of 196 half-maximal activation (V0.5 act) to more negative potentials. This shift was not observed when 197 KV6.4-Met419 was co-expressed with KV2.1 ( Figure S3D ). The current amplitude generated was 198 similar between wild-type KV6.4 or KV6.4-Met419 co-expressed with KV2.1 ( Figure S3E) showing that expression of KV6.4-Met419 does not negatively regulate maximal current flux, over wild-type 200 KV6.4, a factor that would impact sensory neurone excitability ( Figure S3E ). The slope factors of 201 the Boltzmann fits did not significantly differ between the 3 groups (KV2.1: k = 9.5 ± 0.8, n = 13; 202 KV2.1 + KV6.4: k = 15.9 ± 1.7, n = 14; KV2.1 + KV6.4-Met419: k = 11.0 ± 0.8, n = 13; one-way 203 ANOVA, P > 0.05). Furthermore, the reversal potential was not significantly different between the 204 groups ( Figure S3F ). 205 Similar to previous reports (23) ScTx from the total IK in the absence of ScTx, we isolated the ScTx-sensitive IK, which is 266 predominantly dependent on KV2 channels ( Figure 3C-F) . A diverse and heterogenous population 267 of KV2 and silent KV subunits is expressed in sensory neurones (29, 32, 33) and previous studies 268 suggest that silent KV subunits only heterotetramerise with KV2 subunits and not KV1, KV3 and KV4 269 subunits (24). As such, we predicted that wild-type KV6.4 heterotetramerisation with KV2.1 in 270 sensory neurones would produce functional channels, but with a hyperpolarised shift in the voltage-271 dependence of inactivation compared to homotetrameric KV2.1 channels, as we ( Figure 1D -G) and 272 others have observed previously in HEK293 cells (24) 45.1 ± 7.7 %; Student's t-test, P = 0.37; Figure 3C -E). The voltage-dependence of ScTx-sensitive 281 IK activation was similar for neurones transfected with KV6.4 or KV6.4-Met419 subunit (V1/2 = −5.4 282 ± 1.8 mV vs. −9.8 ± 1.1 mV, and k = 8.6 ± 1.5 vs. 8.9 ± 0.9, respectively; Figure S5 ). As observed 283 previously (33) , the voltage-dependence of ScTx-sensitive IK inactivation, for both KV6.4 and 284 KV6.4-Met419 experiments, was multifactorial and fitted with a sum of two Boltzmann functions. (33) . 290 Importantly, expression of KV6.4-Met419 led to a significant depolarising shift in the second component of the voltage-dependence of inactivation (−33.8 ± 2.1 mV, n = 7, unpaired t-test, P = 292 0.003, Figure 3F ), whilst the first component, attributed to homotetrameric KV2.1 IK, remained 293 unchanged (-36.2 ± 3.3 mV, unpaired t-test, P = 0.29, Table S4A ). 294 We assessed the functional consequences on neuronal excitability of such a shift in the availability 295 of KV2 channels towards more depolarised potentials through current clamp experiments. The 296 threshold for action potential discharge was assessed for neurones transfected with either KV6.4 or 297 KV6.4-Met419, as well as neurones which exhibited no mCherry fluorescence from cultures Figure 3I ). The ability of neurones to respond to capsaicin was 309 also examined to identify putative nociceptors (i.e. those expressing Trpv1), but no obvious pattern 310 regarding the subpopulations of nociceptive and non-nociceptive neurones within each group could 311 be observed. Analyses of other action potential parameters revealed no further differences between 312 neurones transfected with either KV6.4 construct or untransfected cells (Table S4B) Figure 4C) . 334 In addition, we investigated whether KV6.4-Met419 might affect heterotetramerisation with KV2.1. 335 Co-immunoprecipitation experiments in transfected HEK293 cells demonstrate that, unlike KV6.4, 336 KV6.4-Met419 is unable to bind to KV2.1 ( Figure S6 ). When KV6.4 is tagged but co-expressed with 337 KV6.4-Met419 (untagged), there is notably reduced binding of KV6.4 to KV2.1 ( Figure 5A ). 338 Similarly, by immunofluorescence analysis, the presence of untagged KV6.4-Met419 suffices to 339 disrupt KV6.4 trafficking to the plasma membrane ( Figure 5B and 5C ). 340 We therefore conclude that the KV6.4-Met419 variant acts as a dominant negative subunit and 341 significantly affects the function of KV6.4 (and hence in turn KV2.1) in the heterozygote state 342 identified in our cohort of women who did not require analgesia during their first labour.
343
DISCUSSION
345
Parturition may be physiological and widely considered to be 'natural' but remains amongst the 346 most painful events in life that women can experience (34). Labour pain is a complex experience 347 with many biopsychosocial determinants, of which visceral nociception is fundamental and 348 necessary. Although the cellular and molecular substrates for visceral nociception are ill defined in 349 humans, ion channels that are important regulators of uterine sensory neurone excitability, may 350 determine visceral nociception and hence labour pain. 351 Labour pain is challenging, if not impossible, to model adequately in pre-clinical laboratories. Our 352 genetic approach in humans here was not to discover very rare Mendelian mutations that cause 353 extreme and hence, pathological painlessness (e.g. Congenital Insensitivity to Pain). Instead, we 354 sought to investigate SNPs that are more common, and for which frequencies in the general 355 population are known. We hypothesised that such SNPs would be significantly over-or under-356 presented in a cohort of women with a less extreme, but nonetheless clinically relevant phenotype. 357 Hence, we chose to investigate healthy nulliparous women who chose and were able to manage 358 pain from spontaneous and uncomplicated vaginal delivery of term labour without any analgesia. 359 In this group, there were no deficits in detection of innocuous warmth, cool or cuff-grip pressure to 360 suggest clinically relevant sensory neuropathy. There were also no differences in cognitive test 361 battery performance, pain-relevant personality traits or emotional function, when compared to 362 controls. However, these women demonstrate increased pain and tolerance thresholds to a range of 363 noxious stimuli, and significantly so for cuff-pressure pain. 364 Given that our painlessness phenotype is far less extreme compared to that of congenital 365 insensitivity to pain, we did not expect that any rare-SNP(s) discovered in this study would cause a 366 large increase in experimental pain threshold or tolerance for all stimulus modalities. Nonetheless, 367 there is modest evidence from a study by Carvalho and colleagues that a composite of these 368 measures obtained just before induction of labour in singleton, term pregnancies, predicts analgesic 369 consumption, i.e. volume of local anaesthetic infused, in women who requested an epidural (35). 370 The women recruited in the Carvalho cohort resembled the controls we employed in that they used 371 analgesics during nulliparous labour. Our observation here that women who did not request any 372 analgesic (epidural or Entonox) had an overall increase in experimental pain thresholds compared 373 to controls is reassuringly consistent. However, the finding that cuff-pressure pain threshold was 374 robustly and very significantly increased in those women is novel. Labour pain has visceral and 375 somatic components, caused by contractions of uterine viscus, but also by sustained stretch or 376 compression of pelvic floor, perineum and vagina (4), which occur in the later stages of labour as the foetus descends, and may be experienced as a continuous background pain on which rhythmic 378 pain caused by uterine contractions is superimposed (36). Whilst speculative, the hypothesis that 379 women with high cuff-pressure pain thresholds would report reduced intensity of continuous 380 background pain during labour is testable. 381 Blinding was not feasible in our experiments and social desirability bias may explain our overall 382 findings of increased threshold and tolerance of pain. However, such bias might be expected to also 383 significantly lower scores for self-reported pain related traits, particularly pain catastrophizing (11), 384 but that was not observed. Our data are consistent with those from other investigators who show 385 that scores from Pain Catastrophizing Scale and Fear of Pain questionnaires do not influence self-386 reported or behavioural measures of labour pain (37). Pain is a complex experience, with sensory-387 discriminatory and affective-motivational aspects (38) . We found that the test cohort had lower 388 SFMPQ scores that pertained to the sensory, but not the affective qualities of the pain that was 389 experienced during cold tolerance testing. In sum, we found increased threshold to pain from 390 noxious stimuli (significantly so for cuff pressure), but no differences in cognitive, personality traits 391 and emotional function, in women who did not require analgesics during term nulliparous labour. 392 These findings suggest that nociceptive function is altered in these women and validate their 393 selection to discover predisposing genetic changes in sensory neurones (nociceptors) that might 394 influence labour pain in women: a phenotype that otherwise would confidently have been expected 395 to be highly heterogeneous. 396 We detected a single SNP, rs140124801 in the gene KCNG4 where the rare allele had a significant 397 over-representation when compared to the general population in a cohort of 158 women who had 398 no analgesic requirement during nulliparous labour, noting that ideally control allele frequencies 399 would have been generated from a matched cohort of women who did require analgesia. There were 400 4 heterozygotes who possess the rare allele, and data on quantitative sensory and pain testing were 401 available for 3 heterozygotes. We found that women who possess the rare allele showed a 402 significantly increased cuff-pressure pain threshold, when compared to controls (Supplemental 403 materials; Table S3 ). The rare allele of SNP rs140124801 causes a mis-sense change p.Val419Met 404 in KV6.4, a silent KV subunit that forms heterotetramers with KV2 channels and modulates their 405 function (23). We, and others, show that KV6.4 traffics to the plasma membrane only when co-406 expressed with KV2.1 (25) . In contrast, we found that the rare allele product KV6.4-Met419 failed 407 to traffic to the plasma membrane when co-expressed with KV2.1. Moreover, KV6.4-Met419 failed 408 to induce the hyperpolarising shift in the voltage-dependence of KV2.1 inactivation that is observed with KV6.4, likely indicating that the observed currents would be conducted by KV2.1 410 homotetrameric channels. 411 We have found that KV6.4-Met419 was unable to heterotetramerise with KV2.1. A possible 412 explanation for this is gained from X-ray crystallography of KV2.1 homotetramer (RCSB Protein 413 Data Bank ID: 3LNM; and see Supplemental data). Each of the four KV2.1 monomers contributes 414 equally to the K + ion selectivity region, which is formed by the peptide backbone carbonyl groups 415 of the amino acids TVGYG. The side chains of Valine and Tyrosine from each of the four 416 monomers fits within an aliphatic pocket of the adjacent monomer (composed of amino acids 417 WWAIIS, see Figure 1C ). The rare allele of SNP, rs140124801 results in Valine being changed to 418 Methionine, the side chain of which is too large to be accommodated by this aliphatic pocket. This 419 may be sufficient to stop KV6.4 forming a heterotetramer with KV2.1 and would be predicted to 420 disrupt the close packing of the peptide backbone carbonyl groups of the ion selectivity region. 421 For KV6.4 to modulate labour pain it needs to be expressed in an appropriate part of the sensory 422 nervous system. We focused on uterine sensory neurones, but this does not negate the possibility 423 that KV6.4 also exerts influence elsewhere in the nervous system, KCNG4 mRNA also being 424 expressed in regions of the spinal cord and brain ( Figure S7 ). We observed KV6.4 expression in 425 Trpv1 and NaV1.8-positive mouse uterine sensory neurones, consistent with the observation that 426 sensory neurones innervating deep tissues display comparatively high Trpv1 expression (39). 427 Results from unbiased single-cell RNA-sequencing of mouse DRG obtained from cervical to 428 lumbar levels reveal no specific coexpression of KV6.4 in nociceptive Trpv1/Scn10a expressing 429 neurones (32). However, single-cell RNA-sequencing of colonic sensory neurones identified that 430 KV6.4 does co-localise with Trpv1 and NaV1.8 (29), consistent with our findings here that KV6.4, 431 Trpv1 and NaV1.8 are coexpressed in uterine sensory neurones from T12-L2 and L5-S2 DRG. 432 Taken together, these data suggest that KV6.4 might be a marker for sensory neurones that innervate 433 the viscera. Due to the restricted expression of Kcng4 in a particular sensory neurone type, 434 expression of KV6.4-Met419 is expected to reduce excitability specifically for this class of sensory 435 neurones. 436 For the rare allele rs140124801 to modulate labour pain it needs to cause a significant change in 437 KV6.4-influenced neuronal activity, and to do so in the heterozygote state. Our electrophysiology 438 and cell trafficking studies showed that the mutant KV6.4-Met419, as opposed to KV6.4, had no 439 effect on KV2.1 function, nor was it trafficked to the plasma membrane. Transfection of KV6.4 into 440 mouse sensory neurones produced a more hyperpolarised voltage-dependence of inactivation for 441 the predicted heterotetrameric KV2/silent KV channel component of IK than when KV6.4-Met419 was transfected, further supporting the hypothesis that the loss-of-function KV6.4-Met419 results 443 in more KV2.1 activity at positive voltages. KV2.1 is known to contribute to the after-444 hyperpolarisation duration, intra-action potential refractory period, and thus regulate neuronal 445 excitability (27) . Hence, we anticipated that a KV6.4-Met419-induced deficit in KV2.1 function 446 would likely result in fewer action potentials and thus less pain during periods of sustained 447 nociceptor activity, such as that occurring with uterine contractions during labour. Although we did 448 not observe a difference in the after-hyperpolarisation duration or action potential frequency 449 between sensory neurones transfected with KV6.4 or KV6.4-Met419 (possibly due to the continual 450 current injection used), we did find that a larger amount of current was required to cause Met419 expressing neurones to fire actions potentials and thus conclude that the mutation confers 452 reduced neuronal excitability. Critically, we observed that KV6.4-Met419 has a dominant negative 453 effect on KV6.4, regarding modulation of the voltage-dependence of inactivation for KV2.1. This 454 result likely explains the reduction in labour pain seen in individuals in our cohort who were 455 heterozygotes for the SNP rs140124801 rare allele. 456 There is a growing understanding of the distinctions between the neural pathways for pain from 457 visceral and somatic tissues: each have evolved nociceptors that sense damage in different physical 458 environments (40). Our findings suggest a key role for KV6.4 in specifically regulating nociceptor 459 excitability, and hence pain, in normal labour. Kv6.4 is also expressed in other parts of the nervous 460 system ( Figure S7 ) and its expression in non-neural tissues is unknown. However, we found that 461 women carrying the rare allele KCNG4 managed nulliparous labour without analgesics, have higher For psychometric and quantitative sensory testing, statistical analyses were performed with R 506 Studio (Version 1.1.442). The mean and standard deviation were generated for each outcome 507 variable for test and control cohorts. Shapiro-Wilk tests and F-tests were used assess data normality 508 and differences in variances. Differences between the means of each outcome variable in test and 509 control cohorts were assessed using tests for two independent samples, using 510 Welch's t-test or Mann-Whitney U tests when the relevant assumptions were met. The level of 511 statistical significance was adjusted using Sidak's correction. The correction applied to multiple 512 outcomes associated with each domain of assessments: questionnaires, CANTAB, sensory 513 detection, pain thresholds and tolerance. 514 For statistical assessment of the genetic data collected in this study, enrichment of amino acid 515 altering SNPs was assessed by exome sequencing, with exome vcf, bam and bam.bai files 516 iteratively analyzed to extract data on all SNPs in or near to exons, including the depth and quality 517 of the sequence data, and the alleles detected (9). For each SNP the allele frequencies were 518 compared to normal values derived from the 1000 genomes project and exome variant server, and 519 deviations assessed for significance using a Chi-squared test with two tails and Yates correction. 520 The resulting P values were subject separately to a Bonferroni and FDR correction, as 521 approximately 100,000 SNPs were assessed in our fSNPd method. 522 We then focused only on ion channels, defined as being identified by the Gene Ontology Term 523 GO:0005216 (423 genes, which were also hand curated and checked against a Pfizer/Neusentis 524 database that had been shared with us). There were 28 SNPs found in ion channels and each was in 525 a different gene; there was only one detected SNP in KCNG4. Eight of these SNPs were then 526 eliminated because the protein change caused by the rare allele was common in the orthologous 527 mammalian proteins. For the remaining 20 SNPs, we determined the allele frequency of each of the 528 by use of the Integrated Genome Viewer examining the cohort's exome bam files individually. This 529 led to the elimination of 19 SNPs, 14 as the common allele frequency was 100% and program errors 530 in assigning alleles within our discovery cohort had falsely appeared to show a deviation from 531 100%, and five because of misalignment of reads to homologous genes leading to errors in SNP 532 allele calling and SNP allele frequency calculation. 533 Further statistical tests used to assess differences between KV6.4 and KV6.4-Met419 throughout the 534 study are unpaired t-tests and ANOVA with Bonferroni's multiple comparison post-hoc test, as 535 described in the relevant figure legends and Supplementary Methods. Differences between groups were considered significant at a P value < 0.05, and were tested using GraphPad (Prism5.0, 537 California, USA).
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